Add BrightSurf on Google Email

Slow release of a drug, TT-10, improves heart attack recovery in a mouse model

Researchers found that slow release of TT-10 from nanoparticles improved heart function after a heart attack, accompanied by increased cardiomyocyte proliferation and smaller infarct size. The study suggests that PLGA nanoparticles could be used to improve treatment administration efficiency for cardiovascular drugs.

SourceUniversity of Alabama at Birmingham·JournalJCI Insight·TypeExperimental study·DateOct 22, 2021

Flu and heart disease: The surprising connection that should convince you to schedule your shot

A recent review published in the Journal of the American Heart Association found that flu vaccination can significantly reduce the risk of heart attack and stroke in individuals with heart disease. Despite higher mortality rates from influenza, many Americans under 65 with heart disease have low vaccination rates.

SourceHouston Methodist·JournalJournal of the American Heart Association·TypeSystematic review·DateOct 15, 2021

Edoxaban may be effective treatment for atrial fibrillation after transcatheter aortic valve replacement

A large-scale international study found that edoxaban is non-inferior to warfarin for efficacy in preventing adverse events, but led to higher bleeding complications. The trial suggests that treatment with edoxaban can be valuable in managing AF patients after TAVR, especially when a lower dose of edoxaban is used.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateAug 28, 2021

Age-related decline in two sirtuin enzymes alters mitochondrial dynamics, weakens cardiac contractions

A preclinical study found that age-related decline in two sirtuin enzymes alters mitochondrial dynamics, weakening cardiac contractions in response to ischemia-reperfusion injury. Boosting SIRT1/SIRT3 levels may help protect against such injuries, potentially reducing heart attack complications and deaths.

SourceUniversity of South Florida (USF Health)·JournalAging Cell·TypeExperimental study·DateAug 24, 2021

Implementation of primary PCI in the management of STEMI in Egypt

A study in Egypt identified significant barriers to primary PCI implementation in STEMI management, including prehospital and emergency department delays. The findings highlight the need for improvement in STEMI networks, training of interventional cardiologists, and hospital policies to enhance patient care.

SourceCompuscript Ltd·JournalCardiovascular Innovations and Applications·DateAug 19, 2021

New research lifts the lid on cardiac microvascular dysfunction and could help many patients with unexplained heart disease

A new study found that 44% of micro-arteries from patients had abnormal myogenic tone, associated with excessive caldesmon presence and poor cell alignment. This abnormality affects blood supply within the heart and other organs, impacting quality of life and life expectancy.

SourceUniversity of Bristol·JournalCardiovascular Research·TypeObservational study·DateAug 9, 2021

Repairing hearts with deadly spider venom

A drug candidate developed from a molecule in the venom of the Fraser Island funnel web spider can prevent damage caused by a heart attack and extend donor heart life for organ transplants. The treatment blocks a death signal sent from the heart after an attack, reducing cell death and improving survival.

SourceUniversity of Queensland·JournalCirculation·DateJul 16, 2021

Emergency care for heart attacks and strokes rebounds

A Kaiser Permanente study found that hospitalization rates for heart attacks remained stable during subsequent COVID-19 surges, contrary to initial declines during the pandemic's onset. The research suggests effective public health campaigns encouraged people to seek care, resulting in a rebound of hospitalizations.

SourceKaiser Permanente·JournalJAMA·DateJun 9, 2021

International COVID registry finds inequities in heart attack outcomes based on ethnicity

The study analyzed over 1,600 patients with STEMI during the COVID-19 pandemic and found that those with COVID-19 positive status had higher in-hospital mortality and were less likely to receive diagnostic angiograms. Additionally, patients of minority ethnicity and with diabetes had poorer outcomes.

SourceSociety for Cardiovascular Angiography and Interventions·JournalJournal of the American College of Cardiology·DateApr 28, 2021

Review: Changing views on atherosclerosis

Recent advances in understanding atherosclerosis have shifted traditional views on who is at risk for heart attacks and strokes, highlighting the importance of HDL cholesterol, triglycerides, and inflammation. This review paper explores these changes and their implications for treatment and prevention.

SourceBrigham and Women's Hospital·JournalNature·DateApr 21, 2021

Heart failure and stroke rising in men under 40

A University of Gothenburg study found a significant increase in heart failure and stroke cases among men under 40 in Sweden, attributed to rising obesity rates and declining physical fitness. The study monitored over 1.2 million men for 20 years, revealing a sharp decline in heart attacks despite increasing obesity.

SourceUniversity of Gothenburg·JournalJournal of Internal Medicine·DateApr 8, 2021

New imaging technology could help predict heart attacks

Researchers developed a new intravascular imaging technique, ILSI, which can detect unstable coronary plaques. The technique provides a direct assessment of mechanical stability, allowing for early detection and treatment of high-risk vulnerable plaques.

SourceOptica·JournalBiomedical Optics Express·DateMar 16, 2021